The Journal of Urology
Volume 182, Issue 2 , Pages 616-625, August 2009

Association of Lower Urinary Tract Symptoms and the Metabolic Syndrome: Results From the Boston Area Community Health Survey

  • Varant Kupelian

      Affiliations

    • New England Research Institutes, Watertown, Massachusetts
    • Corresponding Author InformationCorrespondence: New England Research Institutes, 9 Galen St., Watertown, Massachusetts 02472 (telephone: 617- 923-7747 ext 293; FAX: 617-924-0968)
  • ,
  • Kevin T. McVary

      Affiliations

    • Department of Urology, Northwestern University, Chicago, Illinois
    • Financial interest and/or other relationship with GlaxoSmithKline, Pfizer, Lilly/ICOS, Sanofi-Aventis, Allergan, and the National Institute of Diabetes and Digestive and Kidney Diseases.
  • ,
  • Steven A. Kaplan

      Affiliations

    • Cornell University, Weill Medical College, New York, New York
  • ,
  • Susan A. Hall

      Affiliations

    • New England Research Institutes, Watertown, Massachusetts
  • ,
  • Carol L. Link

      Affiliations

    • New England Research Institutes, Watertown, Massachusetts
  • ,
  • Lalitha Padmanabhan Aiyer

      Affiliations

    • Pfizer Inc, New York, New York
    • Financial interest and/or other relationship with Pfizer, Inc.
  • ,
  • Patrick Mollon

      Affiliations

    • Pfizer Ltd, Global Medical and Outcomes Research, Sandwich, United Kingdom
  • ,
  • Nihad Tamimi

      Affiliations

    • Pfizer Inc, New York, New York
    • Financial interest and/or other relationship with Pfizer, Inc.
  • ,
  • Raymond C. Rosen

      Affiliations

    • New England Research Institutes, Watertown, Massachusetts
    • Financial interest and/or other relationship with Pfizer Inc., Eli Lilly, Bayer Schering, Sanofi Aventis and Boehringer Ingelheim.
  • ,
  • John B. McKinlay

      Affiliations

    • New England Research Institutes, Watertown, Massachusetts
    • Requests for reprints: New England Research Institutes, 9 Galen St., Watertown, Massachusetts 02472 (telephone: 617-923-7747 ext. 512; FAX: 617-926-8246; e-mail: bach@neriscience.com).

Received 2 December 2008 published online 18 June 2009.

Purpose

In this study we investigated the relationship between lower urinary tract symptoms as defined by the American Urological Association symptom index and the metabolic syndrome, and determined the relationship between individual symptoms comprising the American Urological Association symptom index and the metabolic syndrome.

Materials and Methods

The Boston Area Community Health Survey used a 2-stage cluster design to recruit a random sample of 2,301 men 30 to 79 years old. Analyses were conducted on 1,899 men who provided blood samples. Urological symptoms comprising the American Urological Association symptom index were included in the analysis. The metabolic syndrome was defined using a modification of the Adult Treatment Panel III guidelines. The association between lower urinary tract symptoms and the metabolic syndrome was assessed using odds ratios and 95% confidence intervals estimated using logistic regression models.

Results

Increased odds of the metabolic syndrome were observed in men with mild to severe symptoms (American Urological Association symptom index 2 to 35) compared to those with an American Urological Association symptom index score of 0 or 1 (multivariate OR 1.68, 95% CI 1.21–2.35). A statistically significant association was observed between the metabolic syndrome and a voiding symptom score of 5 or greater (multivariate adjusted OR 1.73, 95% CI 1.06–2.80) but not for a storage symptom score of 4 or greater (multivariate adjusted OR 0.94, 95% CI 0.66–1.33). Increased odds of the metabolic syndrome were observed even with mild symptoms, primarily for incomplete emptying, intermittency and nocturia. These associations were observed primarily in younger men (younger than 60 years) and were null in older men (60 years old or older).

Conclusions

The observed association between urological symptoms and the metabolic syndrome provides further evidence of common underlying factors between lower urinary tract symptoms and chronic conditions outside the urinary tract.

Key Words: metabolic syndrome X, urinary tract, signs and symptoms, epidemiology

Abbreviations and Acronyms: ATP III, Adult Treatment Panel III, AUASI, American Urological Association symptom index, BACH, Boston Area Community Health, BMI, body mass index, BPH, benign prostatic hyperplasia, CES-D, Center for Epidemiological Studies–Depression scale, HDL, high-density lipoprotein, LUTS, lower urinary tract symptoms, MetS, the metabolic syndrome, NHANES III, Third National Health and Nutrition Examination Survey, SES, socioeconomic status

 

 Study received institutional review board approval.

 Supported by Pfizer, Inc.

 The BACH survey is supported by DK 56842 from the National Institute of Diabetes and Digestive and Kidney Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases or the National Institutes of Health.

PII: S0022-5347(09)00934-3

doi:10.1016/j.juro.2009.04.025

The Journal of Urology
Volume 182, Issue 2 , Pages 616-625, August 2009